Evusheld drug approved for use in people aged 12 and older who are immunocompromised or for whom COVID-19 vaccination is not recommended.
Health Canada has authorized a drug developed by AstraZeneca to prevent COVID-19 infections.
Evusheld has been cleared for people aged 12 and older who have a compromised immune system and are unlikely to get an adequate response to a COVID-19 vaccination, or for whom COVID-19 vaccination is not recommended.
The medication contains lab-made antibodies designed to remain in the body for months, which officials say will contain the virus if there is an infection.
The therapy has also been authorized in the United States and has been recommended by the European Medicines Agency.

Big Night Out Raises Over $100,000 for BBBS Oxford
Deadline Looms for RRHS Online Survey
Charity of Choice Applications Open for 2027
SUV Stolen in Waterford
Ingersoll Church Looking for Affordable Housing Partnership
Youth Charged in Hate Motivated Crime
Oxford Hospitals Receive Funding for Life Saving Surgeries
Interview with the Mayor - November 2nd, 2026
Oxford Leaders Release Joint Statement Regarding Landfill Legislation
PJHL Recap - Oct 30th to Nov 1st
Navy Vets Recap - Nov 1st
United Way Burger Battle Begins!
Oxford County Releases Survey Results
Cheese and Cheers Coming to Woodstock
PJHL Preview - Oct 30th to Nov 1st
Daylight Saving Time Ends Sunday
Halloween Safety Tips from WPS
Patrick Stewart Dead at 86
SWOX Crash Results in Minor Injuries
Comments
Add a comment